other cardiovascular — % Change
Johnson & Johnson other cardiovascular — % Change remained flat by 0.0% to 1.1% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 37.7%, from 1.7% to 1.1%. Over 2 years (FY 2023 to FY 2025), other cardiovascular — % Change shows a downward trend with a -22.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Positive growth signals successful product lifecycle management or market expansion, whereas negative growth may indicate declining demand or the impact of product obsolescence.
Detailed definition
This metric measures the period-over-period percentage growth or decline in revenue for the company's secondary cardiova...
Peer comparison
Comparable to organic revenue growth rates reported by diversified medical device manufacturers for specific sub-segments or product categories.
jnj_segment_other_cardiovascular_changeHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | 7.1% | 6.9% | 4.3% |
| YoY Change | — | -2.8% | -37.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's other cardiovascular — % change?
- Johnson & Johnson (JNJ) reported other cardiovascular — % change of 1.1% in Q4 2025.
- How has Johnson & Johnson's other cardiovascular — % change changed year-over-year?
- Johnson & Johnson's other cardiovascular — % change decreased by 37.7% year-over-year, from 1.7% to 1.1%.
- What is the long-term trend for Johnson & Johnson's other cardiovascular — % change?
- Over 2 years (2023 to 2025), Johnson & Johnson's other cardiovascular — % change has grown at a -22.2% compound annual growth rate (CAGR), from 7.1% to 4.3%.
- What does other cardiovascular — % change mean?
- The percentage growth or decline in revenue for secondary cardiovascular products compared to a previous period.